Alteration of the N6-methyladenosine methylation landscape in a mouse model of polycystic ovary syndrome

Abstract Objective To explore the N6-methyladenosine (m6A) methylation abnormality of mRNAs and its potential roles in the mouse model of polycystic ovary syndrome (PCOS). Methods The mouse model of PCOS were induced by injecting dehydroepiandrosterone (DHEA), and confirmed by observing the morpholo...

Full description

Bibliographic Details
Published in:	Journal of Ovarian Research
Main Authors:	Lingxiao Zou, Waixing Li, Dabao Xu, Shujuan Zhu, Bin Jiang
Format:	Article
Language:	English
Published:	BMC 2023-08-01
Subjects:	N6-methyladenosine mRNA Polycystic ovary syndrome Epitranscriptomic microarray PI3K/AKT pathway
Online Access:	https://doi.org/10.1186/s13048-023-01246-7

Similar Items

Correction: Alteration of the N6‑methyladenosine methylation landscape in a mouse model of polycystic ovary syndrome
by: Lingxiao Zou, et al.
Published: (2024-06-01)

The emerging roles of N6-methyladenosine (m6A) deregulation in polycystic ovary syndrome
by: Leyi Jiang, et al.
Published: (2025-05-01)

Polycystic Ovary Induction in Mouse by Testosterone Enanthate
by: Zahra Kalhori, et al.
Published: (2013-12-01)

Kisspeptin regulates the proliferation and apoptosis of ovary granulosa cells in polycystic ovary syndrome by modulating the PI3K/AKT/ERK signalling pathway
by: Pingping Sun, et al.
Published: (2023-01-01)

The RNA Modification N6-methyladenosine and Its Implications in Human Disease
by: Pedro J. Batista
Published: (2017-06-01)

Study on the mechanism of action of berberine combined with Jianpi Yishen Huazhuo formulation in treating obese polycystic ovary syndrome by activating PI3K/AKT signaling pathway
by: Xiaojing Zhang, et al.
Published: (2025-12-01)

Polycystic Ovary Syndrome in Adolescence
by: Rebecca Deans
Published: (2019-10-01)

Network pharmacology and experimental validation to elucidate the mechanism of the treatment of polycystic ovary syndrome with insulin resistance by Resina Draconis
by: Jing Wang, et al.
Published: (2025-05-01)

Estrogen Receptors in Polycystic Ovary Syndrome
by: Xue-Ling Xu, et al.
Published: (2021-02-01)

Integrating Bibliometrics and Bioinformatics to Map Knowledge Structure, Trends, and Genetic Insights in Polycystic Ovary Syndrome and Tumors (2015&ndash;2024)
by: Liu M, et al.
Published: (2025-08-01)

Quinoa ameliorates polycystic ovary syndrome via regulating gut microbiota through PI3K/AKT/mTOR pathway and autophagy
by: Jinfang Dou, et al.
Published: (2024-10-01)

Estimation of the hepcidin level and some Biochemical parameters in patients of polycystic ovary Syndrome in Kirkuk city
by: Sherin Bahgat Ayed AL- Tikriti, et al.
Published: (2019-08-01)

Impact of headache in women with polycystic ovary syndrome
by: Lina Zabulienë, et al.
Published: (2021-12-01)

Effects of Berberine on glucolipid metabolism among dehydroepiandrosterone-induced rats of polycystic ovary syndrome with insulin-resistance
by: Li Li, et al.
Published: (2024-01-01)

Integrated bioinformatics and network pharmacology to explore the therapeutic target and molecular mechanisms of Bailing capsule on polycystic ovary syndrome
by: Hao-ru Guan, et al.
Published: (2023-12-01)

Valproate, Menstrual Disorder and Polycystic Ovaries
by: J Gordon Millichap
Published: (2000-08-01)

Hyperinsulinemia impairs decidualization via AKT-NR4A1 signaling: new insight into polycystic ovary syndrome (PCOS)-related infertility
by: Nan-Xing Jiang, et al.
Published: (2024-02-01)

Epigenetic regulation in cognitive impairment: Focus on N6‐methyladenosine modification and its potential role in perioperative neurocognitive disorders
by: Ting Liu, et al.
Published: (2025-09-01)

Study of the Relationship between the Sonographic Appearance of the Ovaries in Polycystic Ovary Syndrome and Different PCO Phenotypes
by: Farideh Marmazi, et al.
Published: (2025-07-01)

The relationship between intestinal microbiota and polycystic ovary syndrome
by: Katarzyna Korabiusz, et al.
Published: (2019-05-01)

The role of color doppler imaging in the diagnosis of polycystic ovary syndrome
by: Amit Shankhwar, et al.
Published: (2024-07-01)

The Relationship of Anti-Mullerian Hormone in Polycystic Ovary Syndrome Patients with Different Subgroups
by: Ran Y, et al.
Published: (2021-03-01)

Anxiety and Depression in Women with Polycystic Ovary Syndrome
by: Paweł Dybciak, et al.
Published: (2022-07-01)

The conservative treatment in adolescents with the Polycystic ovary syndrome
by: Adrian NEACȘU, et al.
Published: (2016-12-01)

Altered cooperativeness in patients with polycystic ovary syndrome
by: Erson Aksu, et al.
Published: (2019-10-01)

The prevalence of polycystic ovaries in infertility by laparoscopy ‎
by: Tahereh Ziaie, et al.
Published: (2013-09-01)

Evaluation of Thyroid Function Status in Polycystic Ovary Syndrome
by: Dr. Syeda Sobia Harmain1 , Dr. Mohd Inayatulla Khan2
Published: (2020-04-01)

Advances in mitochondrial dysfunction in women with polycystic ovary syndrome
by: Bai Jiali, et al.
Published: (2023-03-01)

Systematic transcriptomic analysis of childhood medulloblastoma identifies N6-methyladenosine-dependent lncRNA signatures associated with molecular subtype, immune cell infiltration, and prognosis
by: Kandarp Joshi, et al.
Published: (2024-08-01)

Knowledge graph construction based on granulosa cells transcriptome from polycystic ovary syndrome with normoandrogen and hyperandrogen
by: Wensu Liu, et al.
Published: (2024-02-01)

Examination of newborn DNA methylation among women with polycystic ovary syndrome/hirsutism
by: Kristen J. Polinski, et al.
Published: (2023-12-01)

Study of association of global deoxyribonucleic acid methylation in women with polycystic ovary syndrome
by: Rudra Prasanna Ray, et al.
Published: (2022-01-01)

Multiparametric arterial spin-labeling and diffusion-weighted imaging of phenotyping of polycystic ovaries
by: Heba M. Abou El-Atta, et al.
Published: (2024-03-01)

Obesity and Polycystic Ovary Syndrome
by: Jin Ju Kim
Published: (2024-12-01)

Clinical Outcome and Hormone Profiles Before and After Laparoscopic Electroincision of the Ovaries in Women With Polycystic Ovary Syndrome
by: Zulfo Godinjak, et al.
Published: (2007-05-01)

ER stress-induced LINC00173 promotes the apoptosis of ovarian granulosa cells by regulating the HRK/PI3K/AKT pathway in polycystic ovary syndrome
by: Yuanyuan Zhao, et al.
Published: (2024-10-01)

Changes in the microbiome in women with polycystic ovary syndrome
by: V.V. Artyomenko, et al.
Published: (2023-06-01)

Effects of antioxidant supplementation for polycystic ovary syndrome
by: Olga Łopacińska, et al.
Published: (2024-05-01)

Polycystic Ovary Syndrome: Pathophysiology and Controversies in Diagnosis
by: Duaa Fahs, et al.
Published: (2023-04-01)

Roles of N6‐methyladenosine epitranscriptome in non‐alcoholic fatty liver disease and hepatocellular carcinoma
by: Yuyan Chen, et al.
Published: (2023-08-01)